BACKGROUND: In 1983 G. Buess, in Germany, developed transanal endoscopic microsurgery (TEM), a new minimally invasive technique for the treatment of rectal tumors. METHODS: Rectal lesions are excised through a modified rectoscope of 40 mm in diameter under stereoscopic control in the gas-dilated rectal cavity. Full-thickness excision, partial-wall excision, or mucosectomy can be performed. Seventy-one patients were treated with the TEM technique in our department. Major complications were observed in one patient (1.4%). No mortality was reported. RESULTS: Histological examination revealed 40 (56.3%) villous adenomas, 6 (8.4%) pT1; 17 (23.9%) pT2; 5 (7%) pT3 carcinomas; and 3 ((4.2%) other lesions. The recurrence rate was 2.8% for adenomas and 2.8% for carcinomas. The overall survival at mean follow-up of 17 months was 96.4%. CONCLUSIONS: The advantages of TEM are less or no postoperative pain, unrestricted mobility, short hospitalization, quick rehabilitation, and absence of skin scars.
BACKGROUND: In 1983 G. Buess, in Germany, developed transanal endoscopic microsurgery (TEM), a new minimally invasive technique for the treatment of rectal tumors. METHODS: Rectal lesions are excised through a modified rectoscope of 40 mm in diameter under stereoscopic control in the gas-dilated rectal cavity. Full-thickness excision, partial-wall excision, or mucosectomy can be performed. Seventy-one patients were treated with the TEM technique in our department. Major complications were observed in one patient (1.4%). No mortality was reported. RESULTS: Histological examination revealed 40 (56.3%) villous adenomas, 6 (8.4%) pT1; 17 (23.9%) pT2; 5 (7%) pT3 carcinomas; and 3 ((4.2%) other lesions. The recurrence rate was 2.8% for adenomas and 2.8% for carcinomas. The overall survival at mean follow-up of 17 months was 96.4%. CONCLUSIONS: The advantages of TEM are less or no postoperative pain, unrestricted mobility, short hospitalization, quick rehabilitation, and absence of skin scars.
Authors: J F Bosset; J J Pavy; H P Hamers; J C Horiot; M C Fabri; P Rougier; F Eschwege; S Schraub Journal: Eur J Cancer Date: 1993 Impact factor: 9.162
Authors: M M Lirici; L Chiavellati; E Lezoche; S Martelli; G Melotti; M Morino; M Guerrieri; I Selmi; S Stipa; L Angelini Journal: Endosc Surg Allied Technol Date: 1994-10
Authors: Christopher D Sutton; Leslie-Jayne Marshall; Steve A White; Neil Flint; David P Berry; Michael J Kelly Journal: Ann Surg Date: 2002-03 Impact factor: 12.969
Authors: Pleun E A Hermsen; Ifesegun D Ayodeji; Wim H C Hop; Geert W M Tetteroo; Eelco J R de Graaf Journal: Surg Endosc Date: 2008-12-06 Impact factor: 4.584